Level and duration of IgG and neutralizing antibodies to SARS-CoV-2 in children with symptomatic or asymptomatic SARS-CoV-2 infection
Alka Khaitan, Dibyadyuti Datta, Caitlin Bond, Michael Goings, Katrina Co, Eliud O. Odhiambo, Lin Zhang, Stephanie Beasley, Josh Poorbaugh, Chandy C. John
doi: https://doi.org/10.1101/2022.04.12.22273466
Alka Khaitan
1IRyan White Center for Pediatric Infectious Diseases and Global Health, Indiana University, Indianapolis, IN, USA
Dibyadyuti Datta
1IRyan White Center for Pediatric Infectious Diseases and Global Health, Indiana University, Indianapolis, IN, USA
Caitlin Bond
1IRyan White Center for Pediatric Infectious Diseases and Global Health, Indiana University, Indianapolis, IN, USA
Michael Goings
1IRyan White Center for Pediatric Infectious Diseases and Global Health, Indiana University, Indianapolis, IN, USA
Katrina Co
1IRyan White Center for Pediatric Infectious Diseases and Global Health, Indiana University, Indianapolis, IN, USA
Eliud O. Odhiambo
1IRyan White Center for Pediatric Infectious Diseases and Global Health, Indiana University, Indianapolis, IN, USA
Lin Zhang
2Eli Lilly and Company, Indianapolis, IN, United States
Stephanie Beasley
2Eli Lilly and Company, Indianapolis, IN, United States
Josh Poorbaugh
2Eli Lilly and Company, Indianapolis, IN, United States
Chandy C. John
1IRyan White Center for Pediatric Infectious Diseases and Global Health, Indiana University, Indianapolis, IN, USA
Data Availability
All data produced in the present work are contained in the manuscript
Posted April 14, 2022.
Level and duration of IgG and neutralizing antibodies to SARS-CoV-2 in children with symptomatic or asymptomatic SARS-CoV-2 infection
Alka Khaitan, Dibyadyuti Datta, Caitlin Bond, Michael Goings, Katrina Co, Eliud O. Odhiambo, Lin Zhang, Stephanie Beasley, Josh Poorbaugh, Chandy C. John
medRxiv 2022.04.12.22273466; doi: https://doi.org/10.1101/2022.04.12.22273466
Level and duration of IgG and neutralizing antibodies to SARS-CoV-2 in children with symptomatic or asymptomatic SARS-CoV-2 infection
Alka Khaitan, Dibyadyuti Datta, Caitlin Bond, Michael Goings, Katrina Co, Eliud O. Odhiambo, Lin Zhang, Stephanie Beasley, Josh Poorbaugh, Chandy C. John
medRxiv 2022.04.12.22273466; doi: https://doi.org/10.1101/2022.04.12.22273466
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2317)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11650)
- Forensic Medicine (10)
- Gastroenterology (687)
- Genetic and Genomic Medicine (3654)
- Geriatric Medicine (343)
- Health Economics (625)
- Health Informatics (2340)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3406)
- Nursing (193)
- Nutrition (512)
- Oncology (1787)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6046)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (391)
- Toxicology (50)
- Transplantation (171)
- Urology (144)